Eva Sutinen

University of Helsinki — Finland

Medicine · Health Sciences

18h-index1.0kcitations47works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(30), Occupational and environmental lung diseases(16), Medical Imaging and Pathology Studies(8), Pleural and Pulmonary Diseases(7), Chronic Obstructive Pulmonary Disease (COPD) Research(5)

Publications47 total

Characterisation of patients with antifibrotic-treated non-idiopathic pulmonary fibrosis progressive pulmonary fibrosis: a retrospective real-life study
BMJ Open·2025Open Access
Abstract B018: <i>Ex vivo</i> modeling of precision immuno-oncology responses in lung cancer
Cancer Immunology Research·2025
Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment
Nature Communications·2025· 17 citedOpen Access
210P Precision immuno-oncology strategies to overcome drug resistance in non-small cell lung cancer
Immuno-Oncology Technology·2024Open Access
190P Ex vivo modeling of precision immuno-oncology responses in lung cancer
Immuno-Oncology Technology·2024Open Access
Ex vivo modeling of precision immuno-oncology responses in lung cancer
Science Advances·2024· 5 citedOpen Access
Health-related quality of life measured with K-BILD is associated with survival in patients with idiopathic pulmonary fibrosis
BMC Pulmonary Medicine·2024· 2 citedOpen Access
Identification of Novel Gene Variants Contributing to Interstitial Lung Diseases in Homogenic Finnish Population
2024
814 Enhancing anti-tumor response in ICI-refractory non-small cell lung cancer through intravenous administration of oncolytic adenovirus armed with hTNFα and hIL-2 in combination with aPD-1 blockade
Regular and Young Investigator Award Abstracts·2023Open Access
KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
Respiratory Research·2023· 6 citedOpen Access
Late Breaking Abstract - A KIF15 missense variant is associated with a distinct prognostic clinical phenotype in idiopathic pulmonary fibrosis
2023· 1 cited
Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer
OncoImmunology·2023· 22 citedOpen Access
Dyspnea Associates With a Widely Impaired Quality of Life in Idiopathic Pulmonary Fibrosis Patients: A Longitudinal Study Using 15D
Journal of Palliative Medicine·2023· 15 cited
Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing
Lung Cancer·2023· 1 cited
A KIF15 Missense Variant is Associated with a Distinct Prognostic Clinical Phenotype in Idiopathic Pulmonary Fibrosis
SSRN Electronic Journal·2023Open Access
Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics
Cell Genomics·2022· 49 citedOpen Access
Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma
Frontiers in Oncology·2022· 9 citedOpen Access
Pulmonary Asbestos Fiber Burden Is Related to Patient Survival in Malignant Pleural Mesothelioma
Journal of Thoracic Oncology·2022· 15 cited
BAP1 germline variants in Finnish patients with malignant mesothelioma
Lung Cancer·2022· 8 citedOpen Access
Leveraging global multi-ancestry meta-analysis in the study of Idiopathic Pulmonary Fibrosis genetics
2021· 14 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Marjukka Myllärniemi(37), Ilkka Ilonen(16), Mari Ainola(11), Mikko Rönty(11), Jari Räsänen(11), Riitta Kaarteenaho(10), Katri Koli(10), Mikko I. Mäyränpää(8), Hely Ollila(8), Juho T. Lehto(7), Olli Ritvos(7), Maria Hollmén(7), Kaisa Rajala(6), Tiina Saarto(6), Juuso Paajanen(6), Henrik Wolff(6), Juulia Partanen(5), Jukka Koskela(5), Kati Mäkelä(5), Sanna Laaksonen(5)